Kinases are an important therapeutic target for drug discovery, and many cancer chemotherapeutic agents have been derived from natural product sources. Natural product samples, however, have the likelihood of assay interference, particularly at elevated test concentrations. The authors developed a competitive fluorescence polarization (FP) assay using red-shifted fluorophores for the AKT kinase and demonstrated utility for testing concentrated natural product extracts. A set of 7 actinomycetes cultures containing indolocarbazoles, known nonselective kinase inhibitors, and a control set of 22 nonproducing indolocarbazole cultures were evaluated. Using red-shifted dyes (Cy3B™ or Cy5™), the authors identified active samples with minimal interference up to the extract concentrations that are 3 times nonextracted culture levels. In contrast, a significant number of interferences were observed using either a fluorescein competitive FP assay or a [ 33 P]ATP Flashplate assay. This work demonstrates that one can screen natural product extracts at high concentrations successfully using FP technology with red-shifted dyes. (Journal of Biomolecular Screening 2004:52-61) 
INTRODUCTION
P ROTEIN KINASES PLAY A CRITICAL ROLE in the cell signaling pathways that regulate many cell functions such as cell growth, differentiation, and apoptosis. Finding potent and selective inhibitors of various tyrosine and serine/threonine protein kinases could provide potential treatments for acute conditions such as cancer 1 or chronic diseases such as rheumatoid arthritis. 2 In particular, the Bcr-Abl tyrosine kinase inhibitor, Gleevec™, is reported to be effective against chronic myelogenous leukemia. [3] [4] [5] AKT kinase, also called protein kinase B, is a key mediator of many signal transduction pathways. 6, 7 It promotes cell survival and cell proliferation by inhibiting apoptosis. [8] [9] [10] It also contributes to tumor progression by regulating cell invasiveness and angiogenesis. 11, 12 Overexpression of AKT has been found in sev-eral types of human cancers. [13] [14] [15] Therefore, AKT inhibitors may be potential drugs for various types of cancer.
Natural products and their structural homologues have been a major source of antitumor drugs from the pharmaceutical industry. Many notable anticancer drugs such as paclitaxel, vinblastine, teniposide, epothilone A and B, dactinomycin, and doxorubicin are from plants or microbes. A number of additional compounds such as the marine product bryostatin1 are in various stages of clinical trials. [16] [17] [18] Natural products have the value of diversity in terms of both bioactivity and chemical structure. 19, 20 Screening natural products in kinase targets such as AKT may lead to novel cancer chemotherapy agents.
There are 3 basic approaches to screening natural products that involve the use of crude extracts, semipurified extracts, and structure-elucidated natural product libraries. [21] [22] [23] Screening crude extracts is a less time-consuming and less costly approach than preparing pure or semipure samples. In addition, crude extracts contain maximal chemical diversity because no purification steps take place, whereas in preparing pure or semipure samples, some components may be lost during the purification process. However, due to the low concentration of minor components in the crude extracts, their activity might not be observed during screening. Therefore, screening concentrated extracts would increase the chance of finding activity in minor components. A major drawback of screening concentrated crude extracts is that color interfer-ence as well as autofluorescence interference could cause false positives and/or false negatives. 17 Over the past few years, advances in high-throughput screening (HTS) technologies provide new ways to remove those technical barriers of screening natural product extracts at elevated concentrations.
Fluorescence polarization (FP) technology has been employed in developing a number of kinase assays. [24] [25] [26] [27] [28] [29] [30] [31] FP assays offer many advantages, particularly for kinase assays. They are homogeneous and sensitive, have a rapid readout, are miniaturizable, contain a single label, and employ a ratiometric detection system, minimizing color quench from compounds tested. We have previously observed that the use of red-shifted dyes such as Cy3B™ and Cy5™ in a FP assay reduces interference from fluorescence compounds and particulate-based light scattering encountered with screening. 31 In addition to FP assay technology, several other technologies have been used successfully to screen kinase targets and other enzyme targets. These include radioactive assay formats, such as scintillation proximity assays 30, [32] [33] [34] and Flashplate assays, 34, 35 and alternative fluorescence-based assay formats, such as homogeneous time-resolved fluorescence (HTRF). 30, 33, 34, 36, 37 The disadvantages of developing radiometric assays are the large consumption of radioactivity, the generation of large amounts of radioactive waste, and interference from colored compounds, leading to false positives. In the case of HTRF, these assays typically require more reagents and dual labels.
In this article, we demonstrate that FP assays developed using longer wavelength fluorophores (Cy3B™ and Cy5™) allowed crude microbial extracts to be screened effectively at elevated concentrations without significant sample interference or incidence of false positives.
MATERIALS AND METHODS

Materials
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Dulbecco's phosphate-buffered saline (D-PBS), ethylenediaminetetraacetic acid (EDTA), and Tris-HCl buffer were purchased from Gibco-BRL (Frederick, MD). Magnesium chloride (MgCl 2 ), dithiothreitol (DTT), sodium orthovanadate (Na 3 VO 4 ), adenosine 5′-triphosphate (ATP), and staurosporine were purchased from Sigma (St. Louis, MO). [ 33 P]ATP and 384well streptavidin (SA)-coated Flashplates were purchased from PerkinElmer Life Sciences (Boston, MA). White and black 384well Nunc plates were purchased from Matrix Technologies (Hudson, NH). MultiScreen-HV plates (0.45-µm filter size) were supplied by Millipore (Bedford, MA). Media ingredients, unless specified, were purchased from generic suppliers. Tryptone and soluble starch were purchased from Difco Laboratories (Livonia, MI). Meat peptone was purchased from Marcor Development Corporation (Carlstadt, NJ). Pharmamedia and ProFlo flour were purchased from Traders Protein (Memphis, TN). Organic solvents were obtained from Fisher Scientific (Pittsburgh, PA) and were of high-performance liquid chromatography (HPLC) grade or better.
AKT protein kinase was isolated and purified from Sf9 cells infected with recombinant baculovirus carrying human AKT as previously described. 38 Peptide substrates RARTSSFAEPG, biotin-RARTSSFAEPG, and fluorescein phosphorylated peptide RARTSpSFAEPGK-Fl were designed in-house and prepared by SynPep (Dublin, CA). Two additional peptides, Cy3B™-RARTSpSFAEPG and Cy5™-RARTSpSFAEPG, were purchased from Amersham Biosciences (Piscataway, NJ). Anti-phospho-GSK3α Ser21 antibody was obtained from Upstate Biotechnology (Lake Placid, NY). HPLC and UV spectral analysis was performed on an Agilent 1100 series system from Agilent Technologies (Palo Alto, CA).
Germination and fermentation procedure
The germination and fermentation studies were carried out in shake flasks. Stock cultures were maintained as frozen whole broths at -80°C in a final concentration of 10% glycerol. The germination medium contained the following (g/L): glucose, 10; trehalose, 10; tryptone, 5; soyflour, 5; and yeast extract, 5. The pH of the germination media was adjusted to 7.2, followed by the addition of CaCO 3 (2 g/L). For each given stock culture, the first germination was accomplished by inoculating 70 mL of the above medium with 2 mL of the stock culture in a 250-mL Erlenmeyer flask. The flask was incubated at 28°C on a rotary shaker at 250 rpm for 96 h. The second germination was completed by taking 2.5 mL of the above seed culture and inoculating another 250-mL Erlenmeyer flask containing 70 mL of the same seed medium. The flask was incubated, as above, for 96 h.
Five percent of the second germination was used to inoculate the fermentation medium. The fermentation was carried out in a 500-mL Erlenmeyer flask containing 100 mL of the fermentation medium. The flask was incubated at 28°C on a rotary shaker at 250 rpm and harvested after 96 h. The fermentation media used contained the following (g/L): The pH of the fermentation media was adjusted to 7.8 prior to autoclaving.
Extraction procedure
The fermentation whole broth was extracted by the following method: a 1:2 (volume-to-volume) mixture of fermentation broth and acetonitrile (ACN) plus 5% NaCl (weight to volume of whole broth) was placed on a reciprocal shaker for 15 min. The upper organic phase was separated and dried under nitrogen gas.
HPLC determinations and UV spectral analysis
The dried samples were reconstituted to a 10× concentration (× stands for fold concentration of extracted components relative to their original fermentation volume) with methanol and analyzed by HPLC using a C 18 reverse-phase column (3 µm, 4.6 × 100-mm Phenomenex Luna-2 column) at 24°C. H 2 O:ACN with 0.1% trifluoroacetic acid (TFA) was used as the mobile phase (0.8 mL/ min). A gradient was run starting at 95:5 H 2 O:ACN to a 50:50 mix at 20 min and continuing to 100% ACN at 29 min. Injection volume was 25 µL. Detection was performed using a photodiode array UV detector at 200 to 600 nm. Absorbance measurements were made at 290 nm. Identification of staurosporine was performed on the basis of similarity in retention times with the chromatographic peak obtained from a staurosporine standard solution. Identification of indolocarbazoles was based on the similarity of each peak's UV absorbance profile to the staurosporine standard's UV profile.
Natural products sample preparation for the kinase assay
The dried whole broth and unfermented media blank extracts were reconstituted in a volume of 100% DMSO to achieve a 150× concentration and sonicated for up to 2 h. The extracts were diluted in water to a concentration of 7.5× in 5% DMSO and filtered by MultiScreen-HV filters. Filtration was found in a series of studies to be necessary to remove particulates visible to the naked eye to obtain reasonable FP measurements. A noticeable residue was left behind on the filters, and cloudiness was removed from the samples. After filtration, the extracts were further diluted with 5% DMSO to the appropriate intermediate concentration for a final concentration of 3×, 1×, 0.5×, and 0.2× with 2% DMSO final in the assay.
AKT FP competitive antibody-based kinase assay
Assay reactions were carried out in black 384-well Nunc plates in buffer containing 20 mM HEPES, 2 mM MgCl 2 , 0.5 mM DTT, and 0.05 mM Na 3 VO 4 , pH 7.5, as previously described with the modification of using a higher tracer concentration, 7.5 nM. 29 The overall reagents in the assay were as follows: microbial extracts at 4 testing concentrations (3×, 1×, 0.5×, and 0.2×), AKT (50 ng), substrate RARTSSFAEPG (1 µM), ATP (2 µM), fluorophore tracer (RARTSpSFAEPGK-Fl, Cy3B™-RARTSpSFAEPG, or Cy5™-RARTSpSFAEPG, each at 7.5 nM), and anti-phospho-GSK-3α Ser21 antibody at varying concentrations (2 ng/µL for the fluorescein tracer or 8 ng/µL for Cy3B™ and Cy5™ tracer) in a final volume of 33 µL/well. These antibody concentrations were chosen based on an antibody titration to the fixed tracer concentration of 7.5 nM to allow 80% to 90% capture of the tracer (data not shown). The mixtures were incubated for 1 h at room temperature and stopped with the addition of 10 µL/well EDTA at a final concentration of 5 mM. FP measurements were obtained on the Molecular Devices Analyst (Sunnyvale, CA). When using fluorescein as the tracer, the Analyst excitation wavelength was set at 485 nm (with a bandwidth of 20 nm) and emission at 530 nm (with a bandwidth of 25 nm). The dichroic filter was 505 nm. For the Cy3B™ tracer, the Analyst was set to excite at 530 nm (with a bandwidth of 25 nm) and emit at 580 nm (with a bandwidth of 10 nm), and the dichroic filter was 560 nm. For the Cy5™ tracer, the Analyst was set to excite at 640 nm (with a bandwidth of 20 nm) and emit at 682 nm (with a bandwidth of 22 nm), and the dichroic filter was 650 nm. Milli-polarization values (mP) were obtained from the Analyst software. Total fluorescence (TF) values were calculated from the parallel and perpendicular emission intensity values, and the parameters on the Analyst for fluorescein-, Cy3B™-, and Cy5™based assays were set as previously described. 31 where mP pos was considered the complete reaction containing no inhibitor in 2% DMSO (positive control), and mP neg was considered complete inhibition using 10 µM staurosporine in 2% DMSO (negative control).
AKT [ 33 P]ATP Flashplate kinase assay
Assay reactions, with a final volume of 33 µL, were performed in white 384-well Nunc plates as previously described. 29 Each enzymatic reaction contained microbial extracts at 4 concentrations (3×, 1×, 0.5×, and 0.2×), AKT (50 ng), substrate biotin-RARTSSFAEPG (0.76 µM), ATP (2 µM), and [ 33 P]ATP (165 nCi/ well). The mixtures were incubated at room temperature for 1 h in assay buffer containing 50 mM Tris-HCl, 10 mM MgCl 2 , 1 mM DTT, and 0.1 mM Na 3 VO 4 , pH 7.5. The reactions were stopped by the addition of 42 µL of a solution consisting of 10 mM EDTA and 0.8 mM ATP in D-PBS. An aliquot, 50 µL, of the reaction mixture from each well was transferred to an SA-coated Flashplate and kept 30 min to trap the biotinylated product. The plates were washed with D-PBS (3 cycles) on an Embla plate washer from Molecular Devices (Sunnyvale, CA), and the plates were counted on a Topcount from PerkinElmer Life Sciences (Boston, MA). Percent inhibition for the Flashplate assay was calculated by the following equation:
where cpm pos was considered the complete reaction containing no inhibitor in 2% DMSO (positive control), and cpm neg was considered complete inhibition using 10 µM staurosporine in 2% DMSO (negative control).
RESULTS AND DISCUSSION
Red-shifted dyes reduce interference in the FP kinase assay
Initially, we measured the TF values of unfermented media blank extracts when placed into the enzymatic reaction with fluorescein, Cy3B™, or Cy5™ peptide tracers, each fixed at 7.5 nM concentration and using the appropriate excitation and emission wavelengths for each given fluorophore. The results are shown in Figure 1 using media A. When using the fluorescein tracer, the TF values increased dramatically with increased extract concentration, such that even at the lowest extract concentration tested, 0.2×, the TF value was doubled. This interference is likely due to the contribution of fluorescent components in the extracts contributing their fluorescence to the fluorescence measurement. Because increased TF values caused by fluorescent samples lead to decreased mP readings and low inhibition values in competitive FP assays, the use of fluorescein as the tracer would hinder the assay's ability to identify real actives and increase the number of false negatives. In the case of the Cy3B™ and Cy5™ tracers (higher wavelengths, ∆λ = 50-152 nm over fluorescein), the TF values generated were insensitive to the increased concentration of the extracts, up to the highest extract concentration tested, 3×. Therefore, by using red-shifted dyes, one would increase the likelihood of identifying true actives when screening. This advantage comes from the fact that red-shifted dyes reduce the number of false negatives caused by fluorescent samples and false positives caused by light scattering.
To examine the possible interference of media extract on the AKT competitive FP assays, a blank extract (media A) was spiked with various concentrations of staurosporine from 0 to 10,000 nM at each extract concentration (0× [also known as no broth], 0.2×, 0.5×, 1×, and 3×). Percent inhibition values were calculated whereby mP pos was considered the complete reaction in the presence of the extract in 2% DMSO, and mP neg was considered complete inhibition in the presence of the extract with 10,000 nM staurosporine in 2% DMSO. The results were graphed in Figure 2 . When fluorescein was used as the tracer, the IC 50 of staurosporine shifted right as the media extract concentration increased, from 89 nM with no extract in the assay to 2300 nM when the extract was at 3× ( Fig. 2A ). However, when using Cy3B™ as the tracer fluorophore, the IC 50 values generated were consistent at the varying extract concentrations, even up to 3× (Fig. 2B ). Cy5™ behaved similarly to Cy3B™ (Fig. 2C) . These results indicated that when longer wavelength fluorophores were used, the fluorescence interference in FP assays was diminished.
Identification of indolocarbazole-producing and indolocarbazole-nonproducing cultures by HPLC and UV analysis
Twenty-nine selected actinomycetes cultures were fermented in 4 different media, as described above in the Materials and Methods section. A number of these cultures were known producers of staurosporine and related indolocarbazoles (nonselective kinase inhibitors). Four different media conditions were chosen to increase the opportunity of finding cultures producing indolocarbazoles as well as identifying media components with minimal interference associated with them in the AKT kinase assay. The cultures were extracted and analyzed by HPLC and UV to confirm production of indolocarbazoles. For example, Figure 3A shows the HPLC profile (milli-absorbance measurement at 290 nm) of culture ATCC21178 (P5) in media C, indicating production of staurosporine (retention time 15.5 min). Additional peaks with retention times between 16 and 21 min show similar UV profiles to that of staurosporine, suggesting the presence of related indolocarbazoles (Fig. 3B) . A staurosporine HPLC chromatogram ( Fig. 4A ) and UV spectra (Fig. 4B ) are shown for comparison purposes. Based on the 29 actinomycete HPLC and UV profiles when compared to those of pure staurosporine, the results indicated that 7 of the 29 actinomycetes were producers of indolocarbazoles (P1-P7), and 22 were nonproducers (NP1-NP22). The taxonomy and indolocarbazole production status is summarized in Table 1 .
Screening of microbial extracts
To evaluate the ability to identify biological activity in screening fermentation-derived microbial extracts, the 29 selected actinomycete cultures were tested with the AKT competitive FP assay. The crude extracts were prepared at 4 varying concentrations of 3×, 1×, 0.5×, and 0.2× final (see Materials and Methods for extracts preparation). The results of screening these extracts at 3× in the AKT FP assay using fluorescein, Cy3B™, or Cy5™ tracers are summarized in Tables 2 and 3 . The results are shown as the presence (+) or absence (-) of significant inhibition (> 30%). Table  2 represents the findings for the 7 indolocarbazole producers (P1-P7), and Table 3 displays the results for the 22 nonproducers (NP1-NP22) based on HPLC and UV data.
In the case of the 7 producers identified by HPLC and UV, the Cy3B™ or Cy5™ tracers gave similar results with no significant interference. Using either fluorophore, all 7 producers were found to inhibit greater than 30% of the AKT kinase activity. However, different media conditions played a role in the indolocarbazoleproducing activity. Five of the cultures-P1, P3, P4, P5, and P6showed activity in the Cy™ dye-based FP assays in all 4 media. Culture P2 only produced HPLC and UV-detectable indolocarbazoles when grown in media A and C but not in media B and D. Likewise, P2 produced bioactivity in media A and C but not in media B and D using the Cy™ dye-based FP assays. In the case of P7, it was a producer in all 4 media based on HPLC and UV, but in the Cy™ dye-based FP assays, it was active in media C and D only. This discrepancy could be due to the possibility that the indolocarbazoles produced in media A and B were not active in this assay or potent enough to inhibit AKT. On the other hand, media C and D contained additional minor peaks in the indolocarbazole region, which could have contributed to the activity seen. When using fluorescein as the tracer, 1 strain was identified as active out of the 7 in media A, 2 strains showed activity in media B and C, and 5 strains showed activity in media D ( Table 2 ). The high false-negative rate was due to high TF values from the extracts' internal fluorescence contributing to the fluorescein tracer 56 www.sbsonline.org Journal of Biomolecular Screening 9(1); 2004
Turek-Etienne et al. A B C fluorescence placed in the assay, leading to decreased mP readings, which affect the inhibition values generated. This additional fluorescence interferes with the assay detection and measurement, even when the microbial extract concentration was as low as 0.2×. Among the 22 nonproducers identified via HPLC and UV, 3 cultures (NP10, NP13, and NP20) in 2 media or in all 4 media showed more than 30% inhibition in the Cy3B™-based AKT FP assay. One of them, NP20 (strain AT2433), has previously been identified as a known producer of indolocarbazoles that are closely related to rebeccamycin. 39 These activities may be associated with indolocarbazole products at a low concentration that were not detectable by UV but were potent inhibitors in the AKT FP assay. In the case of the Cy5™-based assay, the data agree with the Cy3B™-based assay, except for NP10, where it was not active. In all 4 media types, NP10 had no inhibitory activity for AKT in the Cy5™-based assay, whereas in a Cy3B™-based assay, inhibitory activity of AKT was observed in media B and D. NP10 could be a false positive because Cy5™ is shifted further into the red region than Cy3B™, minimizing potential interference from the NP10 sample. When using the fluorescein-based assay, several cultures gave spurious positive activity (NP1 in media D, NP10 in media B and D, NP11 in media C, NP12 in media D, NP13 in all 4 media, NP18 in media B, and NP21 in media B). These inconsistencies that were found when using fluorescein were found infrequently when using the Cy™ dyes when compared to the HPLC and UV results. The large number of inconsistencies with fluorescein was For all the microbial extracts tested at lower concentrations (0.2×, 0.5×, and 1×), similar results were obtained as discussed above (data not shown). Overall, the results suggest that one could screen the microbial extracts in an AKT kinase assay using FP technology up to a 3.0× concentrate when longer wavelength fluorophores such as Cy3B™ and Cy5™ are used; however, fluorescein is not a suitable fluorophore for this application because sample interference causes an increased number of false negatives and false positives.
Red-Shifted Dyes in a Fluorescence Polarization AKT Kinase Assay
To assess the ability to screen microbial extracts successfully using a conventional radiometric format, we developed AKT using a [ 33 P]ATP-based Flashplate method and screened the same set of microbial samples against the kinase. A wash step was introduced into the assay to help reduce the sample interference. The results are summarized in Table 4 for the producers and Table 5 for the nonproducers based on HPLC and UV analysis. This heterogeneous assay confirmed most of the positive cultures, P1-P7, as well as NP13, which was identified in the FP assay. However, it also identified numerous false positives; 13 of the 22 nonproducers were active, giving a high false-positive rate. The reason for this likely comes from the interference or signal quenching caused by the colored samples that had not been washed out (visual inspection). Most natural product extracts tested are highly colored, including many of the extracts tested in this study. This property sug- Turek-Etienne et al. 
Findings are based on percent inhibition for testing of the microbial extracts at 3× concentration. A (+) denotes presence and a (-) denotes absence of significant inhibition (> 30%) for the tested 3× extract concentrate. NP1 through NP22 represent the 22 indolocarbazole nonproducers based on high-performance liquid chromatography (HPLC) and UV.
gests that screening using a traditional radiometric assay is not acceptable even with a wash step. The use of such a format could potentially be misleading. In addition, this method is labor intensive and involves the use of relatively large amounts of radioactivity.
CONCLUSIONS
Screening natural products against kinase targets is an important approach in the search for new cancer chemotherapy drugs.
However, because of the structural diversity of natural product extracts (mixture of hundreds of components that are usually colorful and may contain fluorescent components), color interference and endogenous fluorescence interference could cause both high falsepositive and false-negative hit rates. The possibility of assay interference is accentuated at elevated sample concentrations. Our data demonstrated that by using longer wavelength tracer fluorophores (Cy3B™ and Cy5™) in an FP kinase assay, one can screen microbial extracts at high concentrations with minimal interference. In contrast, an FP assay using fluorescein as a tracer fluorophore would cause numerous false negatives and sometimes false positives. Likewise, the use of a traditional radiometric Flashplate assay increased false positives because of color interference. In summary, an FP kinase assay using red-shifted dyes appears to be a very good option for testing microbial extracts. These dyes may also be useful for assays involving other natural product sources, although they may not suppress fluorescent interference from redand far-red-emitting pigments, such as chlorophyll and other porphyrins. Findings are based on percent inhibition for testing of the microbial extracts at 3× concentration. A (+) denotes presence and a (-) denotes absence of significant inhibition (> 30%) for the tested 3× extract concentrate. P1 through P7 represent the 7 indolocarbazole producers based on high-performance liquid chromatography (HPLC) and UV. a. HPLC/UV results are the same as in Table 2 and shown for convenience. 
Findings are based on percent inhibition for testing of the microbial extracts at 3× concentration. A (+) denotes presence and a (-) denotes absence of significant inhibition (> 30%) for the tested 3× extract concentrate. NP1 through NP22 represent the 22 indolocarbazole nonproducers based on high-performance liquid chromatography (HPLC) and UV. a. HPLC/UV results are the same as in Table 3 and shown for convenience.
